HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers
Nucleic Acids Research · 27.10.2023 · 51 (19) · 10194-10217
DOI: 10.1093/nar/gkad700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 28.08.2023. Verfasst von Viacheslav M Morozov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Histones, Nuclear Proteins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIH HHS.
Abstract (Originalsprache)
Incorporation of histone variant H3.3 comprises active territories of chromatin. Exploring the function of H3.3 in prostate cancer (PC), we found that knockout (KO) of H3.3 chaperone HIRA suppresses PC growth in vitro and in xenograft settings, deregulates androgen-induced gene expression and alters androgen receptor (AR) binding within enhancers of target genes. H3.3 affects transcription in multiple ways, including activation of p300 by phosphorylated H3.3 at Ser-31 (H3.3S31Ph), which results in H3K27 acetylation (H3K27Ac) at enhancers. In turn, H3K27Ac recruits bromodomain protein BRD4 for enhancer-promoter interaction and transcription activation. We observed that HIRA KO reduces H3.3 incorporation, diminishes H3.3S31Ph and H3K27Ac, modifies recruitment of BRD4. These results suggest that H3.3-enriched enhancer chromatin serves as a platform for H3K27Ac-mediated BRD4 recruitment, which interacts with and retains AR at enhancers, resulting in transcription reprogramming. In addition, HIRA KO deregulates glucocorticoid- (GR) driven transcription of genes co-regulated by AR and GR, suggesting a common H3.3/HIRA-dependent mechanism of nuclear receptors function. Expression of HIRA complex proteins is increased in PC compared with normal prostate tissue, especially in high-risk PC groups, and is associated with a negative prognosis. Collectively, our results demonstrate function of HIRA-dependent H3.3 pathway in regulation of nuclear receptors activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA.
- Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL, USA.
- Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
- Department of Molecular Genetics & Microbiology, University of Florida College of Medicine, Gainesville, FL, USA.
- University of Florida Health Cancer Center, Gainesville, FL, USA.
ORCID-Profile: Alberto Riva, Alexander M Ishov
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- NIH HHS
- NIH
- UF Cancer Center Pilot & Exploratory Studies Award
- Fulbright Scholar
- Florida Department of Health
- University of Florida ICBR Bioinformatics Core
Zitieren
APA
Morozov, V. M., Riva, A., Sarwar, S., Kim, W. J., Li, J., Zhou, L., Licht, J. D., Daaka, Y., & Ishov, A. M. (2023). HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. Nucleic Acids Research, 51(19), 10194-10217. https://doi.org/10.1093/nar/gkad700
Vancouver
Morozov VM, Riva A, Sarwar S, Kim WJ, Li J, Zhou L, et al. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. Nucleic Acids Research. 2023;51(19):10194-10217. doi:10.1093/nar/gkad700
BibTeX
@article{Morozov2023,
author = {Morozov, Viacheslav M and Riva, Alberto and Sarwar, Sadia and Kim, Wan-Ju and Li, Jianping and Zhou, Lei and Licht, Jonathan D and Daaka, Yehia and Ishov, Alexander M},
title = {HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {19},
pages = {10194--10217},
doi = {10.1093/nar/gkad700}
}
EUVIMED